Home Applications 021862 Application 021862
Type NDA
Sponsor NOVARTIS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 NEVANAC NEPAFENAC SUSPENSION/DROPS;OPHTHALMIC 0.1% Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021862-001 NEVANAC NEPAFENAC 0.1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2005-08-19
Orange Book patents# Current patent rows page 1 of 1 · 1 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N021862-001 7834059 2027-01-31 U-1095 2010-11-30
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N021862-001 NEVANAC 0.1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2005-08-19 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N021862-001 NEVANAC 0.1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2005-08-19 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N021862-001 NEVANAC 0.1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2005-08-19 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N021862-001 NEVANAC 0.1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2005-08-19 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 4 · 122 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-10-15 13:18:30 2026-09 N021862-001 7834059 2027-01-31 U-1095 2010-11-30 c2088c7a36db…2026-09-14 22:38:34 2026-08 N021862-001 7834059 2027-01-31 U-1095 2010-11-30 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021862-001 7834059 2027-01-31 U-1095 2010-11-30 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021862-001 7834059 2027-01-31 U-1095 2010-11-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021862-001 8071648 2025-12-02 Drug product 2011-12-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021862-001 8324281 2025-12-02 Drug product 2012-12-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021862-001 7834059 2027-01-31 U-1095 2010-11-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021862-001 8071648 2025-12-02 Drug product 2011-12-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021862-001 8324281 2025-12-02 Drug product 2012-12-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021862-001 7834059 2027-01-31 U-1095 2010-11-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021862-001 8071648 2025-12-02 Drug product 2011-12-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021862-001 8324281 2025-12-02 Drug product 2012-12-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021862-001 7834059 2027-01-31 U-1095 2010-11-30 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021862-001 8071648 2025-12-02 Drug product 2011-12-16 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021862-001 8324281 2025-12-02 Drug product 2012-12-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021862-001 7834059 2027-01-31 U-1095 2010-11-30 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021862-001 8071648 2025-12-02 Drug product 2011-12-16 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021862-001 8324281 2025-12-02 Drug product 2012-12-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021862-001 7834059 2027-01-31 U-1095 2010-11-30 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021862-001 8071648 2025-12-02 Drug product 2011-12-16 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021862-001 8324281 2025-12-02 Drug product 2012-12-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021862-001 7834059 2027-01-31 U-1095 2010-11-30 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021862-001 8071648 2025-12-02 Drug product 2011-12-16 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021862-001 8324281 2025-12-02 Drug product 2012-12-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021862-001 7834059 2027-01-31 U-1095 2010-11-30 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021862-001 8071648 2025-12-02 Drug product 2011-12-16 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021862-001 8324281 2025-12-02 Drug product 2012-12-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021862-001 7834059 2027-01-31 U-1095 2010-11-30 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021862-001 8071648 2025-12-02 Drug product 2011-12-16 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021862-001 8324281 2025-12-02 Drug product 2012-12-17 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021862-001 7834059 2027-01-31 U-1095 2010-11-30 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021862-001 8071648 2025-12-02 Drug product 2011-12-16 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021862-001 8324281 2025-12-02 Drug product 2012-12-17 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021862-001 7834059 2027-01-31 U-1095 2010-11-30 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021862-001 8071648 2025-12-02 Drug product 2011-12-16 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021862-001 8324281 2025-12-02 Drug product 2012-12-17 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021862-001 7834059 2027-01-31 U-1095 2010-11-30 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021862-001 8071648 2025-12-02 Drug product 2011-12-16 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021862-001 8324281 2025-12-02 Drug product 2012-12-17 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021862-001 7834059 2027-01-31 U-1095 2010-11-30 1e350fbaab3a…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join NEVANAC NEPAFENAC Harrow Eye, LLC 11b9a0cf-2a70-17ef-e063-6394a90a5d9e 2024-11-05 Warnings, Adverse reactions Exact identifier application applno (NDA): 021862 application number: NDA021862
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 7 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0065-0002 NEVANAC nepafenac Alcon Laboratories, Inc. NDA Current 0065-0002 NEVANAC nepafenac Alcon Laboratories, Inc. NDA Current 0065-0002 NEVANAC nepafenac Alcon Laboratories, Inc. NDA Current 0065-0002 NEVANAC nepafenac Alcon Laboratories, Inc. NDA Current 0065-0002 NEVANAC nepafenac Alcon Laboratories, Inc. NDA Current 0065-0002 NEVANAC nepafenac Alcon Laboratories, Inc. NDA Current 0078-0778 NEVANAC nepafenac Novartis Pharmaceuticals Corporation NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 65162 SUPPL 2020-11-09 65158 SUPPL 2020-11-05 50832 SUPPL 2017-12-22 50781 SUPPL 2017-12-20 6329 SUPPL 2011-07-05 16477 SUPPL 2011-06-27 37780 SUPPL 2008-06-12 42331 ORIG 2005-10-06 16476 ORIG 2005-08-23 6328 ORIG 2005-08-23